Co-Diagnostics Begins Clinical Testing for Respiratory Multiplex PCR Test
The company aims to support FDA 510(k) clearance submission for its point-of-care platform detecting flu A/B, COVID-19, and RSV.
Read More
Search Results for: point-of-care testing
FDA Grants Breakthrough Device Designation to Nanopath’s UTI Diagnostic Platform
The molecular diagnostic system can identify complicated UTI pathogens and antibiotic resistance markers at the point-of-care in approximately 15 minutes.
Read More
Manual Micromanipulation in an Era of Lab Automation
Even as automation accelerates, hands-on micromanipulation remains essential for precision tasks, exploratory research, and applications where human judgment outperforms algorithms.
Read More
Microbix Partners with Sekisui Diagnostics for COVID/Flu Test Quality Controls
The collaboration will provide quality assessment products to support the commercialization of a molecular point-of-care assay for COVID-19 and influenza detection.
Read More
FDA Clears High-Sensitivity Troponin I Assay for Vitros Systems
The quantitative measurement test is designed to aid in myocardial infarction diagnosis using human plasma samples.
Read More